Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Benef Microbes ; 12(2): 137-145, 2021 Apr 12.
Artigo em Inglês | MEDLINE | ID: mdl-33789556

RESUMO

Pharyngitis and tonsillitis are the most common acute respiratory infections (ARIs) in children aged ≤5 years. The analysis of published data showed that some probiotics could decrease the frequency and number of days with ARIs. This study evaluated the safety and efficacy of Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 to reduce the duration and severity of ARI symptoms. This randomised controlled trial included children aged from 6 months to 5 years, with pharyngitis or tonsillitis, who were randomised to receive a probiotic product containing L. reuteri ATCC PTA 5289 and L. reuteri DSM 17938 or placebo, as drops, ingested orally for 10 days as adjuvants to the use of non-steroidal anti-inflammatory drugs. The main outcomes were the duration and severity of ARI symptoms. The secondary outcomes were changes in salivary immunoglobulin A and inflammatory biomarkers. There was no fever on day 2 and subsequent days in the L. reuteri group (37.3 ±0.5 °C vs 38.6±0.3 °C, P<0.05). Beginning on day 3, the severity of sore throat (5±0.9 vs 8±1.2, P<0.05) was lower in the L. reuteri group. Significant differences in the days with runny nose, nasal congestion, days of non-programmed visits to the medical office or emergency department, levels in tumoral necrosis factor-alpha (TNF-alpha) and related costs of treatment were observed in the L. reuteri group. The frequency of adverse events was similar between the groups. Therefore, L. reuteri ATCC PTA 5289 combined with L. reuteri DSM 17938 is a safe and effective adjunct to reduce the symptoms of pharyngitis or tonsillitis in children.


Assuntos
Limosilactobacillus reuteri/fisiologia , Faringite/tratamento farmacológico , Probióticos/administração & dosagem , Tonsilite/tratamento farmacológico , Pré-Escolar , Feminino , Humanos , Imunoglobulina A/imunologia , Lactente , Masculino , Faringite/imunologia , Saliva/imunologia , Tonsilite/imunologia , Fator de Necrose Tumoral alfa/imunologia
2.
Salud Publica Mex ; 41 Suppl 2: S72-81, 1999.
Artigo em Espanhol | MEDLINE | ID: mdl-10850128

RESUMO

OBJECTIVE: To identify exposure factors contributing to lead poisoning in school children from Mexico City. MATERIAL AND METHODS: Cross-sectional study of 340 children. A convenience sample of schools and a random sample of children were selected. A questionnaire was filled out and venous blood samples were taken. Lead levels were measured by atomic absorption spectrophotometry. Statistical analysis consisted of comparison of means using Student's t test and ANOVA. Multiple linear regression was used for multivariate analysis. Logarithmic transformation of lead blood levels were used to account for their non-normal distribution. RESULTS: Geometric means for private and public schools were: GM = 8.76 micrograms/dl, 95% CI = 9.1-10.5; GM = 11.5 micrograms/dl, 95% CI = 9.4-13.5. Lead levels were higher among children from public schools who are male, between 6 and 8 years of age, in first and second grade, whose mothers have a profession, who use glazed earthenware utensils, and who live near glazed earthenware shops or factories. CONCLUSIONS: Exposure predictors of lead blood levels are: being between 6 and 8 years of age, having a professional mother, using glazed earthenware utensils, living near glazed earthenware shops or factories, and studying the second grade of elementary school.


Assuntos
Exposição Ambiental , Chumbo/sangue , Criança , Estudos Transversais , Feminino , Humanos , Masculino , México , Análise de Regressão , Instituições Acadêmicas , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...